Status:
WITHDRAWN
Cetirizine and Famotidine for COVID-19
Lead Sponsor:
Emory University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of cetirizine and famotidine in reducing the duration of symptoms in patients with COVID-19. Secondary aims ...
Detailed Description
COVID-19 is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 may present with a myriad of symptoms ranging from fever and cough to more seve...
Eligibility Criteria
Inclusion
- 18 years old and above
- positive COVID-19 test (antigen or PCR)
- symptomatic from COVID-19
- symptoms less than or equal to 7 days
Exclusion
- already enrolled in another COVID-19 drug study
- chronically taking a H1-receptor antagonist or H2-receptor antagonist
- have taken H1-receptor antagonist or H2-receptor antagonist less than 72 hours from expressed interest in the study.
- history of an adverse reaction to H1 or H2-receptor antagonists
- severe liver disease
- severe renal disease
- taking steroids
- taking hydroxychloroquine and/or azithromycin
- already participating in a COVID-19 vaccine trial
- already received a COVID-19 vaccine
- symptoms greater than 7 days
- have had COVID-19 more than once
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04836806
Start Date
August 1 2021
End Date
July 1 2022
Last Update
August 20 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital at Wesley Woods COVID-19 Testing Facility
Atlanta, Georgia, United States, 30329
2
Emory Healthcare Network Peachtree Immediate Care COVID-19 Testing Centers
Atlanta, Georgia, United States, 30339